Women's Trust in and Use of Information Sources in the Treatment of Menopausal Symptoms

Women's Health Issues

Volumn 19, Issue 2, 2009, Pages 144-153

  Huston, Sally A ^a   Jackowski, Rebekah M ^b   Kirking, Duane M ^c  

^a UNIVERSITY OF GEORGIA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; COOPERATION; FEMALE; HEALTH CARE PERSONNEL; HEALTH SURVEY; HUMAN; INFORMATION SERVICE; KNOWLEDGE; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; MENOPAUSAL SYNDROME; PHARMACIST; TRUST;

ESTROGEN REPLACEMENT THERAPY; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MASS MEDIA; MENOPAUSE; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; TRUST; UNITED STATES; WOMEN'S HEALTH;

EID: 61449140141     PISSN: 10493867     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.whi.2009.01.004     Document Type: Article

References (38)

1. Andrist L.C. The impact of media attention, family history, politics and maturation on women's decisions regarding hormone replacement therapy. Health Care for Women International 19 (1998) 243-260
2. Ayerst Laboratories. Premarin (conjugated estrogen tablets, USP) Patient Package Insert (2002), Wyeth-Ayerst Laboratories, Philadelphia
3. Churchill G.A., and Iacobucci D. Marketing research: Methodological foundations. 9th ed. (2004), South-Western, Florence, KY
4. Clinkingbeard C., Minton B.A., Davis J., and McDermott K. Women's knowledge about menopause, hormone replacement therapy (HRT), and interactions with healthcare providers: an exploratory study. Journal of Women's Health and Gender-Based Medicine 8 (1999) 1097-1102
5. Comrey A.L., and Lee H.B. A first course in factor analysis. 2nd ed. (1992), Lawrence Erlbaum Associates, Hillsdale, NJ
6. Dillman D.A. Mail and Internet surveys. The tailored design method. 2nd ed. (2000), John Wiley & Sons, Inc, New York
7. Frewer L.J., Howard C., Hedderly D., and Shepherd R. What determines trust in information about food-related risks? Underlying psychological constructs. Risk Analysis 16 (1996) 473-486
8. Garamszegi C., Dennerstein E., Dudley E., Guthrie J.R., Ryan M., and Burger H. Menopausal status: Subjectively and objectively defined. Journal of Psychosomatic Obstetrics and Gynaecology 19 (1998) 165-173
9. Gilson L. Trust and the development of health care as a social institution. Social Science & Medicine 56 (2003) 1453-1468
10. Grady D. Cardiovascular disease outcomes during 6.8 years of hormone therapy. Heart and estrogen/progestin replacement study follow up (HERS II). JAMA 288 (2002) 321-333
11. Griffiths F. Women's decisions about whether or not to take hormone replacement therapy: Influence of social and medical factors. The British Journal of General Practice 45 (1995) 477-480
12. Griffiths F. Women's control and choice regarding HRT. Social Science and Medicine 49 (1999) 469-481
13. Guillemin M. Managing menopause: A critical feminist engagement. Scandinavian Journal of Public Health 27 (1999) 273-278
14. Hoffman M., Hammar M., Kjellgren K.I., Lindh-Astrand L., and Brynhildsen J. Changes in women's attitudes towards and use of hormone therapy after HERS and WHI. Maturitas 52 (2005) 11-17
15. Huston S.A. Understanding women's decisions about hormone replacement therapy (2003), University of Michigan Press, Ann Arbor
16. Huston S.A., Kirking D.M., and Shimp L.A. Use, intentions, and beliefs about hormone replacement therapy in women with and without diabetes. Maturitas 55 (2006) 58-68
17. Ingebretsen, M. (2002, December 30). Top health stories of '02: the strange and important. The Wall Street Journal [online version]. Available from: http://online.wsj.com/article/0,SB104117561424046953,00.html.
18. Keating N.L., Cleary P.D., Rossi A.S., Zaslavskky A.M., and Ayanian J.Z. Use of hormone replacement therapy by postmenopausal women in the United States. Annals of Internal Medicine 130 (1999) 545-553
19. Kennedy I. Patients are expert in their own field. British Medical Journal 326 (2003) 1276-1277
20. Korsgaard M.A., Whitener E.M., and Brodt S.E. Trust in the face of conflict: The role of managerial trustworthy behavior and organizational context. Journal of Applied Psychology 87 (2002) 312-319
21. Ma J., Drieling R., and Stafford R.S. US women desire greater professional guidance on hormone and alternative therapies for menopause symptom management. Menopause 13 (2006) 506-516
22. Manson J.E., Allison M.A., Rossouw J.E., Carr J.J., Langer R.D., Hsia J., et al. Estrogen therapy and coronary-artery calcification. New England Journal of Medicine 356 (2007) 2591-2602
23. McCrea F.B. The politics of menopause: the "discovery" of a deficiency disease. Social Problems 31 (1983) 111-123
24. McIntosh J., and Blalock S.J. Effects of media coverage of Women's Health Initiative study on attitudes and behavior of women receiving hormone replacement therapy. American Journal of Health-System Pharmacy 62 (2005) 69-74
25. Mechanic D. Changing medical organization and the erosion of trust. The Milbank Quarterly 74 (1996) 171-189
26. Mechanic D. Public trust and initiatives for new health care partnerships. The Milbank Quarterly 76 (1998) 281-302
27. Robinson J.G., Folsom A.R., Nabulsi A.A., Watson R., Brancati F.L., and Cai J. Can postmenopausal hormone replacement improve plasma lipids in women with diabetes?. Diabetes Care 19 (1996) 480-485
28. Schonberg M.A., Davis R.B., and Wee C.C. After the Women's Health Initiative: Decision making and trust of women taking hormone therapy. Womens Health Issues 15 (2005) 187-195
29. Shojania, K.G., Mariani, S.M., & Lundberg, G.D. (2002). MedGenMed's selection of the top 10 medical/health stories of 2002. Available from: http://www.medscape.com/viewarticle/446310. Accessed December 24, 2002.
30. Slovic P. Perceptions of risk: Reflections on the psychometric paradigm. In: Krimsky S., and Golding D. (Eds). Social theories of risk (1992), Praeger, Westport, CT 117-152
31. Stafford R.S., Saglam D., Causino N., and Blumenthal D. Low rates of hormone replacement in visits to United States primary care physicians. American Journal of Obstetrics and Gynecology 177 (1997) 381-387
32. Suter E., Verhoef M.J., Bockmuehl C., Forest N., Bobey M., and Armitage G.D. Women's approaches to evaluating complementary and alternative therapies for menopausal symptoms. Canadian Family Physician 53 (2007) 84-90
33. Thompson W. Estrogen replacement therapy in practice: Trends and issues. American Journal of Obstetrics and Gynecology 173 (1995) 990-993
34. Tio J., LaCaze A., and Cottrell W.N. Ascertaining consumer perspectives of medication information sources using a modified repertory grid technique. Pharmacy World & Science 29 (2007) 73-80
35. Udell J.A., Fischer M.A., Brookhart M.A., Solomon D.H., and Choudhry N.K. Effect of the Women's Health Initiative on osteoporosis therapy and expenditure in Medicaid. Journal of Bone and Mineral Research 21 (2006) 765-771
36. Watkins E.S. Dispensing with aging: Changing rationales for long-term hormone replacement therapy, 1960-2000. Pharmacy in History 43 (2001) 23-37
37. Whitener E.M., Brodt S.E., Korsgaard M.A., and Werner J. Managers as initiators of trust: An exchange relationship framework for understanding managerial trustworthy behavior. Academy of Management Review 23 (1998) 513-530
38. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Journal of the American Medical Association 288 (2002) 321-333